The standard advice is to avoid repeated freeze-thaw cycles, which is correct and leaves out why. Knowing the mechanism changes what you do about it, because it turns a vague caution into a planning problem with an arithmetic answer.
Three things happen each time a solution freezes and thaws, and none of them is the solution politely pausing.
Freezing concentrates everything
Ice crystallises as pure water. It excludes solutes almost entirely, so as a solution freezes, the peptide, the buffer salts and anything else dissolved are pushed ahead of the advancing ice front into a shrinking volume of still-liquid solution.
By the time freezing is nearly complete, the remaining unfrozen pocket holds nearly all of the original solute in a tiny fraction of the original volume. Its concentration there is many times the nominal concentration on the tube.
That matters because concentration drives the processes that damage a peptide. Aggregation is concentration-dependent, since it requires molecules to meet. Any bimolecular reaction speeds up. The aggregation post covers the mechanism, and the relevant addition here is that a dilute solution in a freezer passes through a brief transient of being a very concentrated one.
The same thing happens in reverse on thawing, which is why a slow thaw holds the solution in that concentrated state for longer than a fast one.
Freezing can move the pH
This is the least-known effect and the most consequential for a buffered solution.
A buffer works because two species, an acid and its conjugate base, are both present. When a buffered solution freezes, those two species do not necessarily remain in solution together; one can crystallise out before the other. The pair is then unbalanced, and the pH of the remaining unfrozen fraction moves, in some systems by more than a unit.
So a solution that was neutral on the bench is not guaranteed to be neutral in the last unfrozen pocket, which is also the most concentrated pocket. The two effects land in the same place at the same time. Since pH is what sets a peptide's charge state and therefore its solubility, and also what drives the hydrolysis routes in which residues degrade first, this is a real mechanism rather than a curiosity. pH and buffer choice covers the selection side.
Each cycle creates a new interface
Ice-water and air-water interfaces are hostile to peptides. A molecule at an interface is partly out of solution, which favours it unfolding and exposing the parts that normally face inward, and exposed hydrophobic surface is what lets molecules associate with each other.
Freezing creates an enormous ice-water interface, because a volume of ice crystals has far more surface area than the tube wall ever did. Thawing destroys it and the next cycle creates it again. This is the mechanism that makes cycles the variable rather than time: a tube sitting frozen and undisturbed has one interface history, and a tube frozen and thawed five times has five.
The fix is arithmetic
Given that, the goal is not careful thawing. It is for every tube to be thawed once.
That is a sizing problem, and it runs backwards from use.
- Work out what one use consumes, including whatever the method wastes in dead volume.
- Add a margin so a tube is not scraped empty, perhaps ten to twenty percent.
- Divide the stock into that volume. Now each tube is thawed once, used, and finished, and the cycle count across the whole stock is one.
A worked example with example numbers: if a single use takes 40 µL and the margin is 10 µL, aliquots of 50 µL from a 1 mL stock give twenty tubes. The cycle count on each is one, and nothing in the set has a freeze-thaw history to argue about.
Three practical notes on doing it.
Aliquot in one session, from one vial entry. The point of aliquoting is defeated if the parent vial is entered twenty times to fill twenty tubes. Draw the whole volume once and dispense. The stopper and seal post covers why entries are the thing to minimise.
Do not go too dilute. Peptides adsorb to container surfaces, and the loss is roughly a fixed quantity per unit of surface area rather than a fixed percentage. At high concentration that loss is negligible; at low concentration the same absolute loss can be a large share of what was in the tube. Very dilute aliquots are therefore the worst case, and low-binding tubes plus a sensible concentration are the answer. Why peptides stick to plastic has the detail.
Label so the tube is self-explanatory. Compound, concentration, solvent, the lot number from the vial, and the date it was made. The lot number is the link back to the certificate, and without it an aliquot found in a freezer in three months is an unknown. How to report research peptides in a methods section covers what a reader of your eventual write-up needs.
If a tube has to be thawed twice
Sometimes the planning fails. A few things reduce the damage, none of which make it free.
Thaw quickly and at a low temperature rather than slowly, so the concentrated transient is short. Thaw to a cold temperature and keep it cold, rather than letting a tube reach room temperature and sit there. Mix gently once thawed, because freeze-concentration leaves the solution genuinely non-uniform and the top of a thawed tube is not the same as the bottom, but swirl rather than shake, since shaking adds the air-water interface you were trying to avoid. And write the cycle count on the tube, because the only thing worse than a twice-thawed aliquot is a twice-thawed aliquot you believe is fresh.
What this does not settle
It does not give you a number of permitted cycles, and this post deliberately gives none. How many cycles a particular peptide in a particular solvent survives before a measurable change is a question for an experiment, and the shape of that experiment is in how to run a peptide stability study. We hold no such data for this catalogue's compounds in solution, and the honest position is that cycle count is a variable to minimise and record rather than one with a published allowance.
It also does not replace the time question. A solution degrades while it sits, frozen or not, and how long a reconstituted peptide lasts is the companion to this one. Aliquoting controls the cycle count. It does not stop the clock.
Frequently asked questions
Why do freeze-thaw cycles matter more than total time frozen?
Because the damage is tied to events rather than duration. Each cycle concentrates the solution into a shrinking unfrozen pocket, can shift the pH of that pocket, and creates a large new ice-water interface. A tube left frozen and undisturbed experiences one of each.
How large should an aliquot be?
Exactly one use plus a small margin for dead volume, which makes the cycle count one for every tube. Working out that volume first is the whole method.
Is it better to thaw slowly or quickly?
Quickly and cold. A slow thaw holds the solution in its freeze-concentrated state for longer, and that state is where aggregation and hydrolysis are fastest.
Can I store very dilute aliquots to save material?
It is the worst case for adsorption. Loss to the tube wall is roughly a fixed amount per unit of surface, so at low concentration it is a large fraction of the contents. Store at a workable concentration in low-binding tubes and dilute at the point of use.
Does the pH really change when a buffer freezes?
In some buffer systems, yes, and by a substantial amount, because the acid and base components of the pair do not necessarily stay in solution together as ice forms. The unfrozen fraction is then both unbalanced in pH and highly concentrated.
How many freeze-thaw cycles can my peptide take?
There is no general answer and this post does not offer one. It depends on the peptide, the solvent and what you are measuring, which makes it an experiment rather than a lookup. Minimise cycles by sizing aliquots to a single use, and record the count.
References
- Pikal-Cleland KA, Rodriguez-Hornedo N, Amidon GL, Carpenter JF. Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems. Journal of Pharmaceutical Sciences 2000;89(8):1049-1057. The pH-shift-on-freezing mechanism. doi.org/10.1002/1520-6017(200008)89:8<1049::aid-jps9>3.0.co;2-5
- Chang BS, Kendrick BS, Carpenter JF. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. Journal of Pharmaceutical Sciences 1996;85(12):1325-1330. Interface-driven denaturation across freeze-thaw cycles. doi.org/10.1021/js960080y
- Kueltzo LA, Wang W, Randolph TW, Carpenter JF. Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze-thawing. Journal of Pharmaceutical Sciences 2008;97(5):1801-1812. doi.org/10.1002/jps.21110
- Goebel-Stengel M, Stengel A, Tache Y, Reeve JR. The importance of using the optimal plastic and glassware in studies involving peptides. Analytical Biochemistry 2011;414(1):38-46. Peptide adsorption to container surfaces and its concentration dependence. doi.org/10.1016/j.ab.2011.02.009
Every product mentioned is sold for laboratory research use only and is not for human or animal use. Nothing on this page describes or recommends use of the material sold here in humans or animals.
